|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.92 USD | -3.05% |
|
-2.33% | +23.12% |
| 06-30 | NovoCure Says Optune Pax Receives CE Mark for Locally Advanced Pancreatic Cancer Treatment | MT |
| 06-29 | NovoCure Limited(NasdaqGS:NVCR) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 1.84B 1.61B 1.49B 1.37B 2.58B 178B 2.64B 17.77B 6.99B 86.97B 6.92B 6.77B 299B | P/E 2026 * |
-10x | P/E 2027 * | -15x |
|---|---|---|---|---|---|
| Enterprise Value | 1.64B 1.43B 1.32B 1.22B 2.29B 157B 2.34B 15.76B 6.2B 77.13B 6.14B 6.01B 266B | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 1.93x |
| Free-Float |
89.99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NovoCure Limited
| 1 day | -3.05% | ||
| 1 week | -2.33% | ||
| Current month | +5.08% | ||
| 1 month | -10.81% | ||
| 3 months | +24.08% | ||
| 6 months | +16.72% | ||
| Current year | +23.12% |
| 1 week | 15.31 |  | 16.52 |
| 1 month | 13.43 | | 18.08 |
| Current year | 9.82 | | 18.92 |
| 1 year | 9.82 | | 18.92 |
| 3 years | 9.82 | | 41.51 |
| 5 years | 9.82 | | 193.01 |
| 10 years | 5.95 | | 232.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Leonard
CEO | Chief Executive Officer | 46 | 01/12/2025 |
| Director of Finance/CFO | 52 | 01/01/2025 | |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | 17/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Asaf Danziger
BRD | Director/Board Member | 59 | 01/01/2012 |
Bill Doyle
CHM | Chairman | 63 | 01/01/2009 |
Kin Yip Leung
BRD | Director/Board Member | 64 | 05/08/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 30/06/26 | Free | Chief Executive Officer | 1,905 | 0.0016% | ||
| 30/06/26 | Free | General Counsel | 1,299 | 0.0011% | ||
| 30/06/26 | Free | Director | 268 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.05% | -2.33% | -1.79% | -60.76% | 1.84B | |
| -0.40% | +0.07% | +38.34% | +1.54% | 12.52B | |
| +10.14% | +11.94% | +22.76% | +26.26% | 6.57B | |
| +2.91% | -0.11% | +54.90% | +31.24% | 5.83B | |
| +6.61% | +10.73% | - | - | 4.75B | |
| -2.77% | -0.34% | -29.86% | +13.57% | 4.25B | |
| -2.01% | +4.84% | -21.83% | -23.97% | 4.02B | |
| -3.31% | -6.97% | -7.39% | +242.25% | 1.8B | |
| 0.00% | +0.66% | +57.87% | -1.45% | 1.56B | |
| -4.73% | -1.40% | -19.85% | -46.64% | 1.28B | |
| Average | +0.34% | +1.70% | +10.35% | +20.23% | 4.44B | |
| Weighted average by Cap. | +1.63% | +2.78% | +19.75% | +15.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 708M 619M 571M 526M 992M 68.18B 1.01B 6.82B 2.68B 33.39B 2.66B 2.6B 115B | 790M 691M 637M 587M 1.11B 76.1B 1.13B 7.62B 3B 37.27B 2.97B 2.9B 128B |
| Net income | -182M -159M -147M -135M -255M -17.55B -261M -1.76B -691M -8.6B -685M -670M -29.59B | -119M -104M -95.64M -88.15M -166M -11.42B -170M -1.14B -450M -5.59B -445M -436M -19.26B |
| Net Debt | -209M -182M -168M -155M -292M -20.08B -299M -2.01B -791M -9.83B -783M -766M -33.86B | -317M -277M -256M -236M -444M -30.54B -454M -3.06B -1.2B -14.96B -1.19B -1.17B -51.5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | $15.92 | -3.05% | 856,319 |
| 16/07/26 | $16.42 | +2.43% | 1,117,924 |
| 15/07/26 | $16.03 | +3.09% | 1,100,966 |
| 14/07/26 | $15.55 | -3.36% | 1,156,812 |
| 13/07/26 | $16.09 | -1.29% | 857,463 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NVCR Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
